Article
Activating AMP-activated protein kinase by an α1 selective activator compound 13 attenuates dexamethasone-induced osteoblast cell death.
Biochemical and biophysical research communications - 18 Mar 2016
Guo Shiguang, Mao Li, Ji Feng, Wang Shouguo, Xie Yue, Fei Haodong, Wang Xiao-dong
Abstract excerpt
Excessive glucocorticoid (GC) usage may lead to non-traumatic femoral head osteonecrosis. Dexamethasone (Dex) exerts cytotoxic effect to cultured osteoblasts. Here, we investigated the potential activity of Compound 13 (C13), a novel α1 selective AMP-activated protein kinase (AMPK) activator, against the process. Our data revealed that C13 pretreatment significantly attenuated Dex-induced apoptosis and necrosis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
